Harimata Company
Harimata develops innovative, scientifically-validated technologies supporting early assessment and therapy of developmental disorders in children like autism, ADHD/ADD, intellectual disability. They specialise in combining experimental psychology with artificial intelligence. Their research and development projects are conducted in line with the highest scientific standards. Their product Play.Care is a tablet-based screening test supporting early detection of autism and other neurodevelopmental disorders in children aged 2–6.
Technology:
Intelligent Data Analysis
Funding Status:
Seed
Number Of Exists:
N/A
Investor Type:
N/A
Investment Stage:
N/A
Headquarters:
Kraków, Poland
Founded Date:
2013
Industry:
Health Care